-
Mashup Score: 2Keynote Lecture by Pamela Kunz to Highlight Need for Inclusive Science in GI Cancers - ASCO - OncoDaily - 2 hour(s) ago
Keynote Lecture by Pamela Kunz to Highlight Need for Inclusive Science in GI Cancers – ASCO / 2025 ASCO GI Cancers Symposium, American Society of Clinical
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2
Researchers share lessons from the first oncology clinical trial in Trinidad and Tobago, which involved a patient named Faith Hill.
Source: www.aacr.orgCategories: General Medicine News, Hem/OncsTweet-
Honored to talk to the @AACR Communications Blog about our @NCItreatment efforts to treat Faith, “Bringing the First Oncology Clinical Trial to Trinidad.” This trial led to the approval of #atezolizumab in patients with this type of sarcoma (#ASPS) https://t.co/F13AsdwUc6
-
-
Mashup Score: 2
Exploring pharmacogenetic testing for DPD deficiency – FDA Oncology / AACR, cancer, DPD deficiency, FDA Oncology, Jennifer Gao, OncoDaily, Oncology, Patricia
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: Exploring pharmacogenetic testing for DPD deficiency - @FDAOncology @drjennifergao @AACRPres https://t.co/mIqeUdnoE3 #Can…
-
-
Mashup Score: 2Putting patients first even during crisis - OncoDaily - 4 day(s) ago
Putting patients first even during crisis / cancer, City of Hope Comprehensive Cancer Center, OncoDaily, Oncology, Ravi Salgia, Sumanta K. Pal
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: Putting patients first even during crisis @montypal @DrRaviSalgia https://t.co/UeYsXa6rB7 #Health #Medicine #Cancer #OncoD…
-
-
Mashup Score: 1On abhorrent science and the weaponization of genomic data - 4 day(s) ago
How to balance open data sharing and public responsibility
Source: theinfinitesimal.substack.comCategories: General Medicine News, Hem/OncsTweet-
RT @SashaGusevPosts: More in the full post here: https://t.co/jAHjOXxNJ1
-
-
Mashup Score: 1Five Efforts by the Centers for Early Detection and Interception - Dana-Farber Cancer Institute - OncoDaily - 5 day(s) ago
Five Efforts by the Centers for Early Detection and Interception – Dana-Farber Cancer Institute / cancer, Cancer Prevention, Centers for Early Detection and
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: Five Efforts by the Centers for Early Detection and Interception - @DanaFarber @DanaFarberNews https://t.co/F2AfmQzM0f…
-
-
Mashup Score: 12Erman Akkus: KRAS mutations in pancreatic cancer - OncoDaily - 5 day(s) ago
Erman Akkus: KRAS mutations in pancreatic cancer / Adenocarcinoma, Amanda Erakky, Amanda Zucker, Anna M. Varghese, cancer, Daniel Muldoon, Erman Akkus, Joanne
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @OncoDailyGI: KRAS mutations in pancreatic cancer - @Erman_Akkus @NatureMedicine @EileenMOReilly @OlcaBasturk https://t.co/ZbPwPiaCI1…
-
-
Mashup Score: 2Fumiko Ladd Chino: 2025 ASCO JCO Journals Editorial Fellow Application is OPEN - OncoDaily - 6 day(s) ago
Fumiko Ladd Chino: 2025 ASCO JCO Journals Editorial Fellow Application is OPEN / ASCO, cancer, Fumiko Ladd Chino, Narrative Medicine, OncoDaily, Oncology
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: 2025 @JCO_ASCO Editorial Fellow Application is OPEN - @fumikochino (@MSKCancerCenter) @ASCO https://t.co/RR610mPRwF #Hea…
-
-
Mashup Score: 2Is Preventative Oophorectomy Safe? - OncoDaily - 6 day(s) ago
Is Preventative Oophorectomy Safe? / cancer, Dana-Farber’s Breast Oncology Center, Douglas E. Drachman, Erica L. Mayer, Megan E. Tesch, OncoDaily, Oncology,
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: Is Preventative Oophorectomy Safe? @MeganTesch (@DanaFarber/@harvardmed) @DFCI_BreastOnc https://t.co/g5MZejDD3O #Health…
-
-
Mashup Score: 1Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer | NEJM - 7 day(s) ago
In an open-label, randomized, phase 3 trial, we compared the efficacy and safety of paclitaxel with that of paclitaxel plus bevacizumab, a monoclonal antibody against vascular endothelial growth fa…
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet-
In my opinion, it’s difficult to say that there is added efficacy without an overall survival advantage… Case in point: https://t.co/iOKqCylwfp https://t.co/X4Q3ENE3Tr
-
RT @oncodaily: Keynote Lecture by @PamelaKunzMD to Highlight Need for Inclusive Science in GI Cancers - @ASCO https://t.co/huAKydhyFC #He…